NOTE: Copyright (c) 1999-2001 by SAS Institute Inc., Cary, NC, USA.
NOTE: SAS (r) Proprietary Software Release 8.2 (TS2M0)
      Licensed to GEORGE WASHINGTON UNIVERSITY-CAMPUSWIDE-T/R, Site 0001180006.
NOTE: This session is executing on the WIN_ME  platform.
 
 
 
WARNING: Entry MRUWSAVE.WSAVE was restored. The entry's data may be truncated.
NOTE: The catalog repair process is complete for SASUSER.PROFILE.CATALOG.
NOTE: SAS initialization used:
      real time           3.07 seconds
 
1    *** S_F.sas from old ST210F;
2    *** revised 4/2004;
3
4    options formdlim = '-';
5
6    filename s_flst 'c:\stat210\sasjobs\jl2003\s_flst.pdf';
7    ods printer pdf file=s_flst;
NOTE: Writing ODS PRINTER output to DISK destination "c:\stat210\sasjobs\jl2003\s_flst.pdf", printer "PDF".
8
9    DATA S210F;
10    INPUT DRUG 1
11          DISEASE 2-3
12          ISBP 4-6
13          MISS 7-9 BSBP 10-13;
14   FSBP=BSBP+ISBP;
15   CARDS;
 
NOTE: The data set WORK.S210F has 72 observations and 6 variables.
NOTE: DATA statement used:
      real time           0.15 seconds
 
 
88   DATA; SET S210F; IF MISS=0;
89   TITLE1 'KUTNER BLOOD PRESSURE DATA -- UNBALANCED DESIGN';
90   TITLE2 'BSBP = BASELINE, FSBP = FOLLOWUP, ISBP = F - B CHANGE';
 
NOTE: There were 72 observations read from the data set WORK.S210F.
NOTE: The data set WORK.DATA1 has 58 observations and 6 variables.
NOTE: DATA statement used:
      real time           0.10 seconds
 
 
91   PROC PRINT;
92
 
NOTE: There were 58 observations read from the data set WORK.DATA1.
NOTE: PROCEDURE PRINT used:
      real time           0.16 seconds
 
 
93   PROC GLM; CLASSES DRUG;
94        MODEL FSBP=DRUG
95         / SOLUTION SS3;
96        LSMEANS DRUG / STDERR PDIFF;
97   TITLE3 'DRUG EFFECT ON FOLLOWUP B.P.,  UNADJUSTED';
98
 
NOTE: PROCEDURE GLM used:
      real time           0.32 seconds
 
 
99   PROC GLM; MODEL FSBP=BSBP;
100  TITLE3 'REGRESSION OF FOLLOWUP ON BASELINE';
101
 
NOTE: PROCEDURE GLM used:
      real time           0.44 seconds
 
 
102  PROC GLM; CLASSES DRUG;
103       MODEL BSBP=DRUG
104        / SOLUTION SS3;
105       LSMEANS DRUG / STDERR PDIFF;
106  TITLE3 'DRUG EFFECT ON Baseline B.P.';
107
 
NOTE: PROCEDURE GLM used:
      real time           0.44 seconds
 
 
108  PROC GLM; CLASSES DRUG;
109       MODEL FSBP=DRUG BSBP
110        / SOLUTION SS3;
111       LSMEANS DRUG / E STDERR PDIFF;
112  TITLE3 'DRUG EFFECT ON FOLLOWUP B.P.,  ADJUSTED FOR BASELINE B.P.';
113
 
NOTE: PROCEDURE GLM used:
      real time           0.60 seconds
 
 
114  PROC GLM; CLASSES DRUG DISEASE;
115       MODEL FSBP=DRUG DISEASE DRUG*DISEASE
116        / SOLUTION SS3;
117       LSMEANS DRUG DISEASE DRUG*DISEASE / STDERR PDIFF;
118  TITLE3 'DRUG BY DISEASE EFFECTS ON FOLLOWUP B.P.,  UNADJUSTED';
119
 
NOTE: PROCEDURE GLM used:
      real time           0.88 seconds
 
 
120  PROC GLM; CLASSES DRUG DISEASE;
121       MODEL BSBP=DRUG DISEASE DRUG*DISEASE
122        / SS3 ;
123       LSMEANS DRUG DISEASE DRUG*DISEASE / STDERR PDIFF;
124  TITLE3 'DRUG BY DISEASE DIFFERENCES IN BASELINE B.P.';
125
 
NOTE: PROCEDURE GLM used:
      real time           0.81 seconds
 
 
126  PROC GLM; CLASSES DRUG DISEASE;
127       MODEL FSBP=DRUG DISEASE DRUG*DISEASE BSBP
128        / SOLUTION SS3;
129       LSMEANS DRUG DISEASE DRUG*DISEASE / STDERR PDIFF;
130  TITLE3 'DRUG BY DISEASE EFFECTS ON FOLLOWUP B.P.,  ADJUSTED FOR BSBP';
131
 
NOTE: PROCEDURE GLM used:
      real time           0.82 seconds
 
 
132  PROC GLM; MODEL ISBP=BSBP;
133  TITLE3 'REGRESSION OF CHANGE ON BASELINE';
134
 
NOTE: PROCEDURE GLM used:
      real time           0.50 seconds
 
 
135  PROC GLM; CLASSES DRUG DISEASE;
136       MODEL ISBP=DRUG DISEASE DRUG*DISEASE
137        / SS3 ;
138       LSMEANS DRUG DISEASE DRUG*DISEASE /  STDERR PDIFF;
139  TITLE3 'DRUG BY DISEASE EFFECTS ON CHANGE IN B.P.,  UNADJUSTED';
140
 
NOTE: PROCEDURE GLM used:
      real time           0.81 seconds
 
 
141  PROC GLM; CLASSES DRUG DISEASE;
142       MODEL ISBP=DRUG DISEASE DRUG*DISEASE BSBP
143        / Solution SS3;
144       LSMEANS DRUG DISEASE DRUG*DISEASE /   STDERR PDIFF;
145  TITLE3 'DRUG BY DISEASE EFFECTS ON CHANGE IN B.P.,  ADJUSTED FOR BSBP';
146
 
NOTE: PROCEDURE GLM used:
      real time           0.94 seconds
 
 
147  PROC GLM; CLASSES DRUG;
148       MODEL FSBP=DRUG BSBP DRUG*BSBP
149        / SOLUTION SS3;
150  TITLE3 'ASSESSMENT OF DRUG BY BSBP INTERACTION -- TEST OF HOMOGENEITY '
151         'OF SLOPES';
152
 
NOTE: PROCEDURE GLM used:
      real time           0.76 seconds
 
 
153  PROC GLM; CLASSES DRUG;
154       MODEL FSBP=DRUG BSBP(DRUG)
155        / SOLUTION SS3;
156  TITLE3 'ASSESSMENT OF DRUG EFFECT WITH NESTED SLOPE MODEL ';
157
 
NOTE: PROCEDURE GLM used:
      real time           0.71 seconds
 
 
158  PROC GLM; CLASSES DRUG DISEASE;
159       MODEL FSBP=DRUG DISEASE DRUG*DISEASE BSBP
160       DRUG*DISEASE*BSBP
161        / SS3;
162  TITLE3 'ASSESEMENT OF HOMOGENEITY OF SLOPES IN THE COMPLETE DESIGN';
163
 
NOTE: PROCEDURE GLM used:
      real time           0.76 seconds
 
 
164  PROC GLM; CLASSES DRUG DISEASE;
165       MODEL FSBP=DRUG DISEASE DRUG*DISEASE BSBP(DRUG*DISEASE)
166        / SOLUTION SS3;
167  TITLE3 'MODEL WITH SEPARATE SLOPES WITHIN CELLS';
168
 
NOTE: PROCEDURE GLM used:
      real time           0.54 seconds
 
 
169  PROC GLM; CLASSES DRUG DISEASE;
170       MODEL FSBP=DRUG DISEASE BSBP
171        / SS3;
172       LSMEANS DRUG DISEASE  / STDERR PDIFF;
173  TITLE3 'NO INTERACTION MODEL WITH COMMON SLOPE FOR BSBP';
174
175  RUN;
 
176
177  ods printer close;
NOTE: ODS PRINTER printed 50 pages to c:\stat210\sasjobs\jl2003\s_flst.pdf.
178
179  run;